TAPI Puerto Rico was acquired at the end of 2005. The Puerto Rico site uses high capacity, flexible equipment with the ability to alternate between products. The site has three main manufacturing buildings dedicated to organics synthesis production. It also has R&D, Kilo Labs and Pilot Plant facilities. The leading products at TAPI Puerto Rico are Lisinopril and Amlodipine. In the coming two years additional important products are planned to be produced at this site.
TAPI Puerto Rico Inc.
State road # 3, km 143.0
Guayama, Puerto Rico 00784, USA
Industrial Park Hwy 3 Km. 76.3
Humacao, Puerto Rico 00741, USA